Forgot your password?
typodupeerror

Comment Re:Thanks EMACS (Score 1) 87

I use Emacs daily, as I have done for 44 years. I use it for all of my programming, for editing flat-file databases, of which I do a great deal, for making notes, and for some kinds of writing. Even if I use LibreOffice Writer for a piece of writing, I will often draft it in Emacs first, then use LibreOffice Writer to format it. I find text-editing, as opposed to formatting, much more efficient in Emacs.

Comment Re:Something wrong (Score 1) 61

But I suppose the real pressure comes from having to top everyone else with dramatic, over-the-top social media photos of [...]

Perhaps, but in this case the real pressure comes from having to justify multiple trillions of dollars of debt, using a technology whose actual scope of applicability is much smaller than you've been leading investors to believe. You can practically see the flop-sweat at this point.

Submission + - Bank of America kindly asks that you don't share your password with your AI asst (techcrunch.com)

schwit1 writes: In an email blast to customers titled “Protecting your finances in the Al World,” Bank of America urged customers to never share their username and password with another person or an outside service, “including an Al-enabled tool or agent that offers to act on your behalf.”

You can practically sense the frustration in the person sending the email. Still, customers are increasingly handing over their log-ins as personal AI assistants grow more popular. Sharing your banking username and password with an AI assistant runs the risk that it could do something with your finances without your knowledge, or that your bank thinks someone’s raiding your account and locks you out of it. Worse, a security flaw in the AI assistant could result in it leaking your banking credentials elsewhere, giving financially motivated hackers a way into your bank account.

Submission + - This frog bacterium wiped out cancer tumors in mice with a single dose (sciencedaily.com)

fahrbot-bot writes: Science Daily has reported that scientists at the Japan Advanced Institute of Science and Technology (JAIST) have identified a naturally occurring bacterium from the intestines of Japanese tree frogs (Dryophytes japonicus) that demonstrated remarkable anticancer activity in mice. The findings, published in Gut Microbes, introduce a new approach to cancer treatment that uses living bacteria to directly target tumors rather than simply altering the gut microbiome.

In a mouse model of colorectal cancer, a single intravenous dose of E. americana completely eliminated tumors, producing a 100% complete response (CR) rate. The researchers emphasize that these findings are limited to mice, but they believe the results provide an encouraging proof of concept for developing new bacterial cancer therapies.

First, E. americana directly attacks tumors. As a facultative anaerobic bacterium, it thrives in both oxygen rich and oxygen poor environments, allowing it to multiply inside the oxygen deprived regions commonly found within tumors. Once there, the bacterial population increased by roughly 3,000 fold within 24 hours after treatment, directly damaging cancer cells.

Second, the bacterium stimulates the immune system. Its presence attracted T cells, B cells, and neutrophils into tumors. These immune cells then released inflammatory signaling molecules, including TNF- and IFN-, which strengthened the immune response and promoted cancer cell death.

One of the most striking findings was that E. americana accumulated almost exclusively inside tumors and did not colonize healthy organs.

They found that the bacteria were rapidly cleared from the bloodstream, with a half life of approximately 1.2 hours, and became undetectable within 24 hours. No bacterial colonization was detected in healthy organs, including the liver, spleen, lungs, kidneys, or heart.

The treatment caused only mild, temporary inflammation that returned to normal within 72 hours. During a 60 day observation period, the researchers found no evidence of chronic toxicity.

Comment Re:Color me surprised (Score 1) 109

Though I'm not sure heavier fines or criminal charges is really going to fix this, it's too easy for executives to rationalize away any risks.

The real fix is more funding for researchers (university and government) so they have the resources to investigate these things on their own. We shouldn't have to rely on companies policing themselves.

Comment Re:A Niche Device on a Great Update Cycle (Score 1) 24

No one is forcing you to upgrade your iPad every 2-3 years just like no one is forcing you to upgrade your iPhone every year. Some people want to upgrade; that is their choice. For some people, they need an additional iPad for their children/spouse etc. For some, their iPad met an unfortunate end. For most of us, we upgrade if and when we need.

Comment Re:Harm (Score 1) 109

While this is true, being the subject of an experiment to see what happens when you do that is not something most people would choose for themselves. It's not *irrational* to be concerned. Absence of evidence on a largely unexplored question like microplastic infiltration in human bodies is not the moral equivalent of absence of evidence in an extensively studied question like a vaccine-autism link.

Slashdot Top Deals

Parallel lines never meet, unless you bend one or both of them.

Working...